PTK2 and non-small cell lung carcinoma: Meanwhile, integrin αvβ3 positive A549/PC-9 cells revealed weakened capability of migration after Y15 and 3CAI treatment (Fig. 2D), suggesting that integrin αvβ3 promoted NSCLC cells proliferation through FAK/AKT signaling pathway.